Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Given that retatrutide is not yet licensed for clinical use in the UK, access is currently limited to participants enrolled in regulated clinical trials
Measurable protein synthesis elevation occurs within 812 hours of the first dose, but subjective recovery improvements reduced soreness, improved ROM typically become noticeable after 35 days of consistent dosing at 2535 mcg daily
Folts JD, Shung AL, Koke JR, Bittar N
Yuan X, Marcano DC, Shin CS, Hua X, Isenhart LC, Pflugfelder SC, et al
The pharmaceutical version remains in Phase 3 clinical trials, with FDA approval expected between late 2026 and early 2027
Some people notice improved energy and mental clarity within days
:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)
US$ 20.34
US$ 20.33
US$ 27.11
US$ 27.13
US$ 21.66
